Bridgefront Capital’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$201K Buy
+4,853
New +$196K 0.05% 454
2025
Q4
– Sell
-9,610
Closed -$293K – 707
2025
Q3
$293K Buy
+9,610
New +$295K 0.09% 404
2025
Q2
– Sell
-6,251
Closed -$219K – 779
2025
Q1
$219K Buy
+6,251
New +$248K 0.06% 491
2024
Q4
– Sell
-4,848
Closed -$211K – 729
2024
Q3
$211K Buy
+4,848
New +$183K 0.08% 442
2023
Q4
– Sell
-6,032
Closed -$272K – 513
2023
Q3
$272K Buy
+6,032
New +$365K 0.19% 228
2022
Q4
– Sell
-3,346
Closed -$291K – 477
2022
Q3
$291K Buy
+3,346
New +$352K 0.3% 141
2022
Q1
– Sell
-1,845
Closed -$333K – 385
2021
Q4
$333K Buy
+1,845
New +$320K 0.32% 122
2021
Q2
– Sell
-3,848
Closed -$500K – 816
2021
Q1
$500K Buy
+3,848
New +$494K 0.16% 234

Other funds holding OMCL

Bridgefront Capital's OMCL Position: Q2 2026 in Review

Bridgefront Capital opened a new position in Omnicell (OMCL) in Q2 2026: 4,853 shares worth $201K. The stake represents 0.05% of the portfolio and ranks #454 among its holdings. This is a return to the name: Bridgefront Capital previously reported a position in OMCL as recently as Q3 2025.

Bridgefront Capital first reported a position in OMCL in Q1 2021 and has held it in 8 quarters since. The position peaked at $500K in Q1 2021. 307 funds tracked by Wall St. Rank hold OMCL as of Q2 2026.

  • Bridgefront Capital held 4,853 shares of Omnicell worth $201K as of Q2 2026.
  • Omnicell was a new Bridgefront Capital position in Q2 2026.
  • Omnicell made up 0.05% of Bridgefront Capital's portfolio in Q2 2026, its #454 holding.
  • Bridgefront Capital first reported a position in Omnicell in Q1 2021 and has held it in 8 quarters since.
  • Bridgefront Capital's Omnicell position peaked at $500K in Q1 2021.
  • 307 funds tracked by Wall St. Rank held Omnicell as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.